Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
51,372,722
-
Total 13F shares
-
665,294
-
Share change
-
-1,906,444
-
Total reported value
-
$1,147,535
-
Price per share
-
$2.07
-
Number of holders
-
10
-
Value change
-
-$2,989,322
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO) as of Q4 2025
As of 31 Dec 2025,
OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
665,294 shares.
The largest 10 holders included
Dauntless Investment Group, LLC, RENAISSANCE TECHNOLOGIES LLC, XTX Topco Ltd, Cerity Partners LLC, GEODE CAPITAL MANAGEMENT, LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, UBS Group AG, EFG International AG, OSAIC HOLDINGS, INC., and MORGAN STANLEY.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.